PA GOODDOCTOR (01833) Reports H1 2025 Revenue of 2.5 Billion Yuan, Net Profit Surges 136.8%

Stock News
2025/08/19

On August 19, 2025, Ping An Healthcare and Technology Company Limited (stock name "PA GOODDOCTOR", 01833, hereinafter referred to as "the Company") announced its interim results for the six months ended June 30, 2025. The data shows that the company maintained steady overall operations with strong growth momentum, achieving dual improvements in revenue and profitability.

During the reporting period, the company recorded total revenue of 2.5 billion yuan, representing a year-on-year increase of 19.5%. Net profit attributable to shareholders reached 134 million yuan, surging 136.8% year-on-year. Notably, revenue from the integrated financial client segment (F-end) and enterprise segment (B-end) corporate health business grew 30.2% year-on-year.

The company has deepened the development of its "medical-insurance synergy" model, continuously strengthening collaboration with Ping An Group's comprehensive financial business. Meanwhile, in the enterprise health management sector, the company has partnered with group members to create a "commercial insurance + health security entrustment + medical and health services" product system, vigorously expanding enterprise clients and achieving steady revenue growth with comprehensive improvement in profitability quality.

During the reporting period, F-end paying users numbered approximately 20 million, up 34.6% year-on-year. The company served over 3,500 paying enterprise clients, with B-end paying users exceeding 3.6 million, representing a 39.2% year-on-year increase.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10